Riskpilot← Back to searchSign inGet full accessCamiCon AB
ABActiveOrg 5567112908Styrmansgatan 1 Lgh 1501Research and experimental development on natural sciences and engineering · NACE 7210Est. 20060 employees
Revenue 2025
SEK 1,6M
-3% vs 2024
EBITDA margin
94.5%
-3% vs 2024
Equity ratio
90.8%
Financial strength
Net profit 2025
SEK 1,3M
-21% vs 2024
| Revenue | SEK 1,6M | -3% |
| EBITDA | SEK 1,6M | -3% |
| Net profit | SEK 1,3M | -21% |
| Total assets | SEK 4,5M | +37% |
| Equity | SEK 4,1M | +45% |
| Employees | 0 | — |
Legal name
CamiCon AB
Org number
5567112908
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
18 september 2006
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget ska bedriva konsultverksamhet inom medicinsk och klinisk utveckling av läkemedel och medicintekniska produkter, affärsplanering, rådgivning och uppföljning av investeringar inom hälso- och livsvetenskaper samt erbjuda tjänster inom arkitektur, inredning och design.
Address
Styrmansgatan 1 Lgh 1501
Email
camilla@camicon.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 662 | 2 332 | 1 450 | 1 701 | 1 645 |
| Staff expenses | — | −576 | −456 | −24 | −5 |
| EBITDA | 1 404 | 1 629 | 942 | 1 601 | 1 554 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 1 404 | 1 629 | 942 | 1 601 | 1 554 |
| Net financials | 2 | 2 | −4 | 99 | 47 |
| Profit before tax | 1 052 | 1 632 | 938 | 2 039 | 1 601 |
| Tax | −229 | −338 | −197 | −427 | −333 |
| Net profit | 823 | 1 294 | 741 | 1 612 | 1 268 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 437 | 2 734 | 2 345 | 3 260 | 4 469 |
| Equity | 1 126 | 1 481 | 1 578 | 2 790 | 4 058 |
| Long-term debt | 110 | 150 | 6 | 24 | 10 |
| Short-term debt | 511 | 414 | 71 | 95 | 50 |
| Total debt | 621 | 564 | 77 | 119 | 61 |
EBITDA margin
94.5%
This company
15.8%
Market median
+498% vs market
20212025
Equity ratio
90.8%
This company
38.2%
Market median
+138% vs market
20212025
Return on equity
31.3%
This company
18.4%
Market median
+70% vs market
20212025
Net profit margin
77.1%
This company
8.1%
Market median
+852% vs market
20212025
Asset turnover
0.37×
This company
1.12×
Market median
-67% vs market
20212025
Debt / equity
0.10×
This company
0.62×
Market median
+84% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of CamiCon AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Camilla Martina Vivianne Lundberg | Chairman | 0 companies |
| Magnus Lundberg | Board of Directors | 0 companies |
| Sebastian Magnus Christian Lundberg | Deputy Board Member | 0 companies |